Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4546 USD | +3.01% |
|
-2.82% | -95.88% |
05-24 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
05-14 | Allarity Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 8M 10.95M |
---|---|---|---|---|---|
Net income 2024 * | -16M -21.88M | Net income 2025 * | -28M -38.3M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.17
x | P/E ratio 2025 * |
-0.29
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Allarity Therapeutics, Inc.
1 day | +3.01% | ||
1 week | -2.82% | ||
Current month | -26.20% | ||
1 month | -27.55% | ||
3 months | -93.52% | ||
6 months | -96.05% | ||
Current year | -95.88% |
![Extreme 0.3871](/images/extremecours_fleche.png)
![Extreme 0.3871](/images/extremecours_fleche.png)
![Extreme 0.3871](/images/extremecours_fleche.png)
![Extreme 0.3871](/images/extremecours_fleche.png)
![Extreme 0.3871](/images/extremecours_fleche.png)
![Extreme 0.3871](/images/extremecours_fleche.png)
![Extreme 0.3871](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-20 |
Chief Tech/Sci/R&D Officer | 63 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 22-09-30 | |
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 23-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-20 | 0.4546 | +3.01% | 1,704,362 |
24-06-18 | 0.4413 | +0.02% | 2,731,940 |
24-06-17 | 0.4412 | -3.01% | 1,998,854 |
24-06-14 | 0.4549 | -2.76% | 2,624,403 |
24-06-13 | 0.4678 | -8.29% | 2,019,981 |
Delayed Quote Nasdaq, June 20, 2024 at 04:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-95.88% | 8M | |
+15.85% | 122B | |
+18.91% | 113B | |
+4.43% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.61% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- ALLR Stock